Zhejiang Pharmaceutical announced that the company plans to repurchase shares through centralized bidding transactions, with an amount not less than 100 million yuan and no more than 200 million yuan. The repurchase price is no more than 1,790 yuan/share, and the number of repurchases is 5.5866 million shares to 11.1732 million shares, accounting for 0.58%-1.16% of the total share capital. The source of capital is owned or raised by itself. Shares are repurchased for employee stock ownership plans or equity incentives, and will be cancelled if not used within 36 months. The implementation period shall not exceed 12 months from the date of review and approval by the board of directors. Furthermore, the company's directors, executives, etc. have no plans to reduce their holdings yet. SDIC Hi-Tech, a shareholder holding 5% or more of the shares, will decide to reduce their holdings depending on the circumstances.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.